Introduction
Deregulated expression of the c-myc oncogene is a common feature of human malignancies (Marcu et al., 1992) . c-Myc protein dimerizes with the basic/helixloop-helix/leucine zipper (b/HLH/LZ) protein Max by its b/HLH/LZ motif and binds to the E-box (CACGTG) in the genome to regulate the transcription of adjacent genes (Luscher and Larsson, 1999) . A co-factor, TRRAP, which is essential for c-Myc-mediated transformation and interacts with the MbI and MbII domains of the c-Myc, has been identified (McMahon et al., 2000) . TRRAP is a part of at least four classes of histone acetyltransferase (HAT) complexes such as SPT3-TAF9-GCN5-acetyltransferase (STAGA) complex, TATA-binding protein-free TAF-containing (TFTC) complex, p300/CBP-associated factor (PCAF) complex and the TIP60-containing complex (Martinez et al., 1998; Ogryzko et al., 1998; Brand et al., 1999; Ikura et al., 2000) . c-Myc, through MbI and MbII domains, recruits these HAT complexes, except for TFTC complex, to regulate transcription (McMahon et al., 2000; Liu et al., 2003) .
The Saccharomyces cerevisiae ortholog of mammalian TRRAP, TRA1, is a component of the yeast SPT-ADA-GCN5-acetyltransferase (SAGA) complex (Saleh et al., 1998) . The yeast SAGA complex is composed of several distinct classes of factors including alteration/deficiency in activation (ADAs), suppressor of Ty (SPTs), TATAbinding protein-associated factors (TAFs), general control non-repressed 5 (GCN5) and TRA1, and acts as a transcriptional coactivator/adapter required at specific promoters (Grant et al., 1998; Hampsey, 1998) . Recently, novel SAGA components such as UBP8, SGF11, SGF29, SGF73 and SUS1 have been identified (Sanders et al., 2002; Rodriguez-Navarro et al., 2004) . Although the SAGA family of HAT complexes has been conserved through evolution, the mammalian orthologs of these yeast proteins have not yet been completely identified. However, TRRAP and GCN5 are essential for the oncogenic activity of c-Myc (McMahon et al., 2000) . Thus, identification of a protein whose expression leads to the activation of c-Myc function would help to elucidate the c-Mycmediated transformation.
In aflatoxinB 1 -induced rat hepatoma K2 cells, the c-myc gene expression is deregulated and its downregulation inhibits the malignant nature of the cells (Sugiyama et al., 2003) . In addition, the function of SGF29 even in yeast SAGA complex is still unknown. In this study, we focused on the identification and functional analysis of rat (r) SGF29, and demonstrated that rSGF29 is a novel component of TFTC/STAGA complexes and its downregulation suppresses tumorigenicity and metastasis.
Results
Deregulated expression of rat SGF29 mRNA in tumor cells Although STAGA complex has an important role in c-Myc-mediated transformation, a mammalian ortholog of yeast (y) SGF29, a component of SAGA complex, has not been identified, and its function is unknown even in yeast. Therefore, we searched for a rat ortholog of ySGF29. A BLAST search identified a rat hypothetical protein (accession number: XP_215064) with 27% sequence identity to ySGF29 and was designated rSGF29. The expression levels of rSGF29 mRNA and protein in K2 cells were higher than in normal liver (Figure 1a and b). The robust expression of rSGF29 gene was also observed in proliferative tissues such as testis. Significant expression of SGF29 mRNA was detected in other rodent tumor cell lines (hepatomas AH70tc and dRLa-74, glioblastoma C6, pheochromocytoma PC12 and embryonal carcinoma P19 cells), whereas in non-tumor cell lines (COS-7, BALB/3T3 and REF52 cells), the expression was very low (Figure 1c ). In K2, AH70tc, dRLa-74, C6 and P19 cells, both rSGF29 and c-myc mRNAs were highly expressed.
Human and mouse orthologs of SGF29 protein have been reported as coiled-coil domain containing 101 (ccdc101; Mammalian Gene Collection Program Team, 2002) . rSGF29 is composed of 293 amino-acid residues, and its molecular mass and isoelectric point are 33267.5 Da and 8.17, respectively. Two coiled-coil domains in the N-terminal region (1-100), two destruction boxes (D-boxes) and a C-terminal nuclear localization signal (NLS) were predicted (Figure 2a) . The database analyses identified orthologs in other eukaryotes (Figure 2b ). rSGF29 protein showed 98 and 27% identities to human and yeast orthologs, respectively.
Involvement of rSGF29 in TFTC/STAGA complexes To confirm the association of rSGF29 with TFTC/ STAGA components, we performed co-immunoprecipitation (co-IP) analysis. In K2 cells, anti-GCN5 antibody co-immunoprecipitated rSGF29 (Figure 3a) . AntirSGF29 antibody also co-immunoprecipitated with rSPT3, a component of TFTC/STAGA complexes ( Figure 3b ). Sepharose 4B gel filtration of the extract from K2 cells expressing FLAG-rADA3 revealed the coexistence of rSGF29, rGCN5, rSPT3 and FLAGrADA3 together with c-Myc in the position of 2-2.2 MDa (Figure 3c ). rGCN5, rSPT3 and FLAG-rADA3 were only detected in the peak fractions, whereas a certain amount of rSGF29 and c-Myc was observed in the lower molecular mass region.
The human lung cDNA library screening by the yeast two-hybrid system using rSGF29 as bait indicated that three out of the 42 b-galactosidase (b-gal)-positive clones encoded hADA3, a component of hGCN5 HAT complexes (Ogryzko et al., 1998) . Mapping the domain of rSGF29 responsible for interaction with rADA3 (accession number: BC097414) by the yeast two-hybrid system showed that the coiled-coil domains of rSGF29 (1-105) participate in the association with the rADA3 N-terminal domain (1-214; Figure 4a and b). The interaction in vitro was analysed by glutathione S-transferase (GST) pull-down assay in which GST-rSGF29 or GST were incubated with 35 S-labelled full-length rADA3 (rADA3 FL), rADA3 N-terminal (rADA3 N; 1-214) and rADA3 C-terminal (rADA3C; 214-432), and detected by autoradiography. The 48.8-kDa rADA3 FL and 24.0-kDa rADA3 N were directly bound to GST-rSGF29 but not GST (Figure 4c ). The 23-kDa band was perhaps because of an immature rADA3 N. Endogenous rSGF29 associated with FLAG-rADA3 (Figure 4d ). To confirm further the interaction, COS-7 cells were cotransfected with GFP-rADA3 and HArSGF29 plasmids and stained with anti-HA antibody followed by a Cy3-conjugated secondary antibody, which showed that rSGF29 and rADA3 coexist in the nuclei (Figure 4e ). These results support that rSGF29 is a component of TFTC/STAGA complexes.
rSGF29 activates c-Myc-dependent transcription To examine whether rSGF29 associates with c-Myc, we performed co-IP analysis. In K2 cells, anti-c-Myc Figure 5b ). In addition, the effect of rSGF29 on the rat ornithine decarboxylase (ODC) gene promoter activity was analysed using the luciferase reporter gene driven by the -769 to þ 309 rODC promoter region (rODC-Luc) containing 2 E-boxes ( Figure 5c ) because the ODC gene is one of the c-Myc target genes (Pena et al., 1993) . COS-7 cells were cotransfected with rODCLuc, c-Myc and rSGF29 expression plasmids. Basal luciferase activity was stimulated approximately 2-fold by c-Myc plasmid. Notably, c-Myc-dependent luciferase activity was dose-dependently enhanced by rSGF29 plasmid.
The effect of the downregulation of rSGF29 on the rODC promoter activity was also investigated. Three small interfering (si) RNA expression vectors against rSGF29 mRNA (siRNA1 for þ 272 to þ 290, siRNA2 for þ 402 to þ 420 and siRNA3 for þ 934 to þ 952) were introduced into K2 cells (Figure 5d ). The expression levels of rSGF29 protein in these transfections were downregulated, and their ODC promoter activities were reduced to approximately 60% of the control siRNA transfection.
Using the chromatin immunoprecipitation (ChIP) assay, the rODC and rat metastasis-associated protein 1 (rMTA1) promoter regions were analysed (Zhang et al., 2005) . rMTA1 and rODC promoters possess 10 and four E-boxes, respectively (Figure 6a ). In growing K2 cells, c-Myc, rSGF29 and acetylated histone H3 were detected in the promoter regions, whereas in the E-boxless promoter of rat acetylcholine receptor (ACHR) gene (Frank et al, 2001) , these proteins were hardly detected ( Figure 6b ). In quiescent K2 cells the binding levels of these proteins were reduced. Thus, the results support the idea that rSGF29 upregulates c-Myc-dependent gene expression.
Involvement of rSGF29 in malignant transformation
To examine whether rSGF29 participates in malignant transformation, we established antisense rSGF29 RNA expression vector-transfected K2 subcell lines SGAS1 and SGAS2. Their expression levels of rSGF29 protein were decreased to 56 and 58% of the parental K2 cells, respectively, whereas the expression level of empty vector-transfected K2V1 cells was similar to that of K2 cells (Figure 7a ). Among these cells the difference in growth rate in monolayer culture was not observed (Figure 7b ). In contrast, the anchorage-independent growth of SGAS1 and SGAS2 cells were significantly reduced as compared with those of the K2 and K2V1 cells (Figure 7c and d) .
The mRNA and protein expression levels of rMTA1 and rODC genes in SGAS1 and SGAS2 cells were substantially reduced as compared with those of the parental K2 cells (Figure 7e ). To confirm the critical role A new mammalian TFTC/STAGA component N Kurabe et al of these genes in anchorage-independent growth, K2 cells were treated with the antisense oligodeoxynucleotides (ODNs) against the flanking region of the translational initiation site of rMTA1 and rODC. These antisense ODNs efficiently downregulated the corresponding proteins (Figure 7f ) and significantly reduced colonization in soft agar as compared with the control nonsense ODN (Figure 7g and h). The non-specific inhibition of protein synthesis was observed in the presence of 2.5 mM nonsense ODN (Sugiyama et al., 2003) .
Suppression of tumorigenicity and lung metastasis by downregulation of rSGF29
To investigate the effects of downregulation of rSGF29 on the tumorigenicity of K2 cells, the antisense transfectants were subcutaneously inoculated into the flank of nude mice. Three weeks after subcutaneous injection into nude mice, K2 and K2V1 cells formed tumors with a mean volume of 1303.8 and 1190.8 mm 3 , respectively, whereas SGAS1 and SGAS2 cells formed smaller tumors with a mean volume of 337.1 and 530.5 mm 3 , respectively (Figure 8a and b) .
The effect of downregulation of rSGF29 on metastasis was analysed by the spontaneous metastatic activity (SMA) and experimental metastatic activity (EMA) tests. The SMA value was determined by counting lung metastatic foci from subcutaneously injected cells, and the mean SMA values of SGAS1 (4) and SGAS2 (20) were lower than those of K2 (85) and K2V1 (93) cells (Figure 8c) . The EMA values of SGAS1 and SGAS2 cells estimated by weighing the lung after intravenous injection were also reduced as compared with those of K2 and K2V1 cells (Figure 8d ). We further established three metastatic tumor subcell lines, K2 LM, K2V1 LM and SGAS1 LM, from the respective original tumors-derived lung metastatic foci. The expression level of rSGF29 protein in SGAS 1 LM cells was restored to that of K2 cells without change of c-myc mRNA expression level (Figure 8e ). Northern blotting with the vector-derived BGH fragment probe showed that the expression level of antisense rSGF29 RNA in SGAS1 LM cells was reduced as compared with that of the parental SGAS1 cells (Figure 8f ). Taken together, these results suggest that rSGF29 could play an important role in tumorigenicity and metastasis.
Discussion
In this study, we identified the rat ortholog of yeast SGF29, rSGF29, whose gene expression was deregulated in various tumor cell lines together with c-myc gene. Gel filtration and co-IP analyses suggest the possibility that rSGF29 associates with the TFTC/ STAGA complexes. This assumption was further supported by yeast two-hybrid screening in which hADA3 cDNA clone was isolated as an rSGF29-binding partner. Genetic studies in yeast have shown that yADA3, an ortholog of hADA3, functions as an adaptor protein between transcription factors and SAGA complex. yADA3 associates with another adaptor yADA2 and is required for GCN5-dependent nucleosomal HAT activity (Saleh et al., 1997; Wang et al., 1998) . By GST pull-down, immunoprecipitation and immunocytochemical staining assay, we showed the direct interaction of rSGF29 with rADA3 in vitro and in vivo. Thus, these results show that rSGF29 is a novel subunit of the TFTC/STAGA complexes.
The recruitment of STAGA but not TFTC complex to the c-Myc N-terminal MbII domain is critical for cMyc-dependent transactivation and transformation (McMahon et al., 2000; Liu et al., 2003) . TRRAP, an integral component of GCN5 HAT complexes including STAGA, is the first factor shown to associate with MbII, and is required for the c-Myc-mediated oncogenic transformation . We demonstrated the endogenous interaction between rSGF29 and c-Myc by immunoprecipitation, gel filtration and immunocytochemical analyses. However, because c-Myc can associate with various proteins depending on the physiological status of the cells to activate or repress transcription, the association of c-Myc with STAGA A new mammalian TFTC/STAGA component N Kurabe et al complex may not be stable. rSGF29 dose-dependently activated the reporter gene driven by the two E-boxes containing the rODC promoter. These results imply that rSGF29 enhances c-Myc transcriptional activity, probably through two mechanisms: stimulation of STAGA HAT activities and increase in the recruitment of the STAGA complexes to c-Myc. ChIP analysis indicated that rSGF29 could bind to the promoter regions of two c-Myc target genes, rMTA1 and rODC, together with c-Myc in growing K2 cells, showing that c-Myc recruits rSGF29 to c-Myc target genes. We also showed that downregulation of rSGF29 reduced the rODC promoter activity. Taken together, these results suggest that rSGF29 is involved in c-Myc-dependent full transactivation and its overexpression may lead to deregulated expression of the c-Myc target genes.
Two downstream genes, MTA1 and ODC, are well documented to cause the c-Myc-mediated malignant phenotypes, including anchorage-independent growth (Nilsson et al., 2005; Zhang et al., 2005) . Downregulation of rSGF29 in K2 cells, in which both rSGF29 and c-myc gene expressions were deregulated, caused the reduction of their colony-forming ability in soft agar, showing that deregulated expression of rSGF29 is implicated in malignant transformation. This result was further confirmed by the data that downregulation of rSGF29 in K2 cells lowered the rMTA1 and rODC gene expressions, and antisense ODNs against both genes inhibited the colony formation of K2 cells. Recent study has shown that the elevated expression of c-Myc could promote metastasis (Pelengaris et al., 2002) . In this study, we demonstrated that downregulation of rSGF29 could reduce tumorigenicity and lung metastasis. Thus, it is possible that the overexpression of rSGF29, at least in part, contributes to c-Myc-mediated malignant transformation via upregulation of the c-Myc target gene expressions including MTA1 and ODC genes. c-Myc-dependent tumorigenicity and metastasis could be suppressed by the block in SGF29 function.
Materials and methods
Complete details are given in Supplementary materials.
Cell culture, transfection and luciferase assays K2 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 5% fetal calf serum (FCS) and then transfected with various expression vectors by lipofection. Luciferase assays were performed according to the manufacturer's protocol (Promega, Madison, WI, USA) and normalized based on b-gal activity as an internal control. The full-length rSGF29 cDNA (rSGF29 FL), N-terminal region (rSGF29 N) and C-terminal region (rSGF29 C) were ligated in-frame with GAL4-DBD in pDBLeu as baits. The full-length rADA3 cDNA (rADA3 FL), N-terminal region (rADA3 N) and C-terminal region (rADA3 C) were ligated in-frame with the GAL4 activation domain in pPC86 as preys. (b) Yeast strain MaV203 was co-transformed with rSGF29 and rADA3 expression constructs and streaked on both selections (-Leu-TrpHis and -Leu-Trp-His þ X-gal). (c) GST pull-down analysis for interaction between rSGF29 and rADA3. GST or GST-rSGF29 fusion protein was incubated with 35 S-labelled rADA3 FL, rADA3 N and rADA3 C and analysed by autoradiography. (d) Endogenous association between rSGF29 and FLAG-rADA3. The cell lysates from COS-7 cells transfected with pFLAG-CMV2-rADA3 or an empty vector were immunoprecipitated with anti-FLAG M2-agarose gel and analysed WB with anti-rSGF29 antibody. (e) Colocalization of rSGF29 and FLAG-rADA3. COS-7 cells were cotransfected with pcDNA3-HA-rSGF29 and pEGFP-C1-rADA3 expression vectors and stained with anti-HA antibody followed by a Cy3-conjugated anti-rabbit IgG antibody. The nuclei were stained with Hoechst 33258. Merging of the Cy3 and GFP images is also shown. Scale bar ¼ 10 mm.
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Plasmid construction
Complete details of all plasmids can be obtained in the Supplementary materials.
Northern blotting
Northern blotting was performed using the full-length rat SGF29, exon 3 of rat c-myc, or BanII fragment (BGH polyA) of pcDNA3 (Invitrogen, Carlsbad, CA, USA) as probes (Sugiyama et al., 2003) .
Immunological analysis
Western blotting (WB) and immunofluorescence analyses were performed as described previously (Urano et al., 2006) . For immunoprecipitation analysis, the lysates prepared with lysis buffer containing 1 mM phenylmethylsulfonyl fluoride (PMSF) were incubated with the desired primary antibodies, precipitated with protein A-Sepharose beads (Sigma, St Louis, MO, USA) and analysed by WB. For immunofluorescence analysis, fixed cells were incubated with the appropriate primary antibodies and treated with fluorescein-conjugated secondary antibodies (Jackson ImmunoResearch, West Grove, PA, USA).
Gel filtration of TFTC/STAGA K2 cells (1 Â 10 8 cells) expressing FLAG-rADA3 were sonicated in the lysis buffer containing 0.1 mM PMSF and centrifuged at 95 000 g for 1 h. The resulting supernatant was fractionated by a Sepharose 4B column (GE Healthcare, Piscataway, NJ, USA) and analysed by WB.
Yeast two-hybrid screening ProQuest two-hybrid human lung cDNA library cloned in the pPC86 vector (Invitrogen) was screened by ProQuest Two-Hybrid System (Invitrogen) in the MaV203 strain. b-gal activity was determined using o-nitrophenyl-b-D-galactopyranoside as a substrate.
GST pull-down assay 35 S-labelled rADA3 FL, rADA3 N and rADA3 C synthesized using TNT Coupled Reticulocyte Lysate Systems (Promega) were incubated with the glutathione beads bound to GSTrSGF29 or GST proteins, separated on sodium dodecyl sulfate-polyacrylamide gel electrophoresis and visualized by autoradiography.
ChIP and RT-PCR Sheared chromatin from growing or quiescent K2 cells were immunoprecipitated with appropriate antibodies and analysed by PCR (Urano et al., 2006) . Then, DNA was extracted and subjected to PCR amplification. The sequences of the primers used in ChIP and reverse transcription-polymerase chain reaction(RT-PCR) are shown in Supplementary Table 1.
Colony formation assays Cells (4 Â 10 3 ) suspended in 0.33% agar medium were layered on a 0.5% solid medium. After 2 weeks, the number of colonies (>150 mm in diameter) was scored.
Treatment with antisense ODNs
The sequences of the antisense ODNs against rMTA1 and rODC were 5 0 -CATGTTGGCGGCCAT-3 0 and 5 0 -AGTAAA GCTGCCCAT-3 0 , respectively. The nonsense ODN consisting ) were seeded in soft agar media containing 1 or 5% FCS. After 2 weeks, the colonies formed in a 1% FCS were photographed (c) and counted after staining with 1-p-iodophenyl-p-nitrophenyl-5-phenyltetrazolium chloride (INT; d). Scale bar ¼ 5 mm. *Significant difference from the K2 cells (Po0.01). (e) Effect of downregulation of rSGF29 on the c-Myc target genes. Expression levels of rMTA1 and rODC mRNA and protein in K2, K2V1 and SGAS1/2 were analysed by RT-PCR and WB, respectively. (f-h) Suppression of colony formation by antisense rMTA1 and rODC ODNs. Expression levels of rMTA1 and rODC in K2 cells treated with antisense rMTA1 and rODC ODNs were analysed by WB (f). Effects of antisense ODNs on the colonization of the cells in soft agar were analysed. The colonies were photographed (g) and counted after INT staining (h). Scale bar ¼ 5 mm. *Significant difference from the random ODNs (Po0.01).
of 15-mer random base sequence was used for the control. The ODNs were transfected into K2 cells by lipofection (Sugiyama et al., 2003) .
Tumorigenicity and metastasis
Tumorigenicity was analysed as described previously (Sugiyama et al., 2003) . For the SMA test, cells (1 Â 10 7 ) were subcutaneously injected into athymic nude mice (n ¼ 5) and lung metastatic foci formed at the end of their lifespan were counted. For EMA test, cells (1 Â 10 6 ) were injected intravenously, and after 7 weeks, the lung was removed and weighed.
Statistical analysis
The significance of the in vitro results was determined by the Student's t-test (two-sided), and in vivo metastasis results were determined by the Kruskal-Wallis test.
